- Home
- ASND vs SOLV Comparison
ASND vs SOLV Comparison
Compare ASND & SOLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- SOLV
- Stock Information
- Founded
- ASND 2006
- SOLV 2023
- Country
- ASND Denmark
- SOLV United States
- Employees
- ASND N/A
- SOLV N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- SOLV
- Sector
- ASND Health Care
- SOLV
- Exchange
- ASND Nasdaq
- SOLV NYSE
- Market Cap
- ASND 10.6B
- SOLV 12.7B
- IPO Year
- ASND 2015
- SOLV N/A
- Fundamental
- Price
- ASND $170.14
- SOLV $74.47
- Analyst Decision
- ASND Strong Buy
- SOLV Hold
- Analyst Count
- ASND 17
- SOLV 11
- Target Price
- ASND $222.18
- SOLV $83.57
- AVG Volume (30 Days)
- ASND 412.4K
- SOLV 678.9K
- Earning Date
- ASND 09-02-2025
- SOLV 08-07-2025
- Dividend Yield
- ASND N/A
- SOLV N/A
- EPS Growth
- ASND N/A
- SOLV N/A
- EPS
- ASND N/A
- SOLV 2.18
- Revenue
- ASND $398,509,511.00
- SOLV $8,308,000,000.00
- Revenue This Year
- ASND $77.19
- SOLV $4.11
- Revenue Next Year
- ASND $75.84
- SOLV $0.14
- P/E Ratio
- ASND N/A
- SOLV $34.19
- Revenue Growth
- ASND 12.06
- SOLV 1.29
- 52 Week Low
- ASND $111.09
- SOLV $54.26
- 52 Week High
- ASND $183.00
- SOLV $85.92
- Technical
- Relative Strength Index (RSI)
- ASND 47.59
- SOLV N/A
- Support Level
- ASND $165.24
- SOLV N/A
- Resistance Level
- ASND $179.96
- SOLV N/A
- Average True Range (ATR)
- ASND 6.21
- SOLV 0.00
- MACD
- ASND -1.07
- SOLV 0.00
- Stochastic Oscillator
- ASND 33.20
- SOLV 0.00
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About SOLV SOLVENTUM CORP
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.